# Hu_2024_The neuroscience of pain, addiction, and anesthesia.

Hu & Zheng. Zool. Res. 2024, 45(3): 709−710

https://doi.org/10.24272/j.issn.2095-8137.2024.138

Editorial

Open Access

The neuroscience of pain, addiction, and anesthesia

 pain,

 and  addiction.

Researchers  and  clinicians  have  long  been  interested  in  the
mechanisms  of
 The
 anesthesia,
International Association for the Study of Pain (IASP) defines
pain  as  an  unpleasant  sensory  and  emotional  experience
associated with, or resembling that associated with, actual or
potential  tissue  damage  (Raja  et al.,  2020).  Drug  addiction
refers  to  a  condition  of  reliance  that  develops  from  regular
drug  consumption,  which  may  lead  to  withdrawal  symptoms
when use is halted. Anesthesia involves the complete loss of
 intravenous
consciousness  induced  by  an  inhaled  or
anesthetic  (Tosello  et al.,  2022).  In  this  special  collection,
Zoological  Research  presents  research  findings  focused  on
pain, addiction, and anesthesia.

The  parabrachial  nucleus  (PBN),  a  gray  matter  structure
located  near  the  cerebellum  at  the  pons,  regulates  various
physiological  activities,  such  as  breathing,  sleeping,  and
feeding, and plays a crucial role in pain transmission within the
central nervous system (Chiang et al., 2019). In this issue, Ke
et al.  (2024)  provide  a  comprehensive  analysis  of  the  distinct
functional  roles  of  lateral  PBN  (lPBN)  subnuclei  in  mediating
sustained pain. Through neuroanatomical tracing, cell-specific
ablation, and chemogenetic silencing, they report that neurons
expressing  the  substance  P  receptor
 in  the
central/superior subdivision of the lPBN (slPBN) are crucial for
mediating  pain-associated  self-care  behaviors  and  aversive
memory.  These  neurons  can  be  activated  by  sustained
noxious thermal and mechanical stimuli applied to the skin or
deep  tissues,  such  as  muscle  or  bone.  In  contrast,  the
external  subdivision  of  the  lPBN  (elPBN)  is  implicated  in
defensive  reactions  to  external  threats  but  not  in  sustained
pain  responses.
 to  our
understanding  of  how  different  brain  regions  coordinate
responses  to  noxious  stimuli  and  highlights  the  complexity  of
pain processing in the central nervous system.

 research  contributes

 (NK1R)

 This

Mild traumatic brain injury (mTBI), accounting for 80%–90%
of  all  TBI  cases,  is  associated  with  post-traumatic  headache
(PTH), a common secondary headache condition (Jiang et al.,
2019;  Lucas  et al.,  2014).  In  this  issue,  Yang  et al.  (2024)
investigate  the  effects  of  mTBI  on  PTH,  exploring  structural
 particularly  metabolic
and  functional
changes
 and
 cortex,
hippocampus. Metabolic analyses reveal significant alterations
in  GABA  and  glutamate  levels,  suggesting  their  potential  as
biomarkers for PTH. These findings imply that the cerebellum
and  temporal  cortex  may  be  key  regions  in  regulating  PTH,
providing targets for future non-invasive clinical treatments.

 in  the  cerebellum,

 brain  abnormalities,

 temporal

This  is  an  open-access  article  distributed  under  the  terms  of  the

Creative  Commons  Attribution  Non-Commercial

 License  (http://

creativecommons.org/licenses/by-nc/4.0/),  which  permits  unrestricted

non-commercial  use,  distribution,  and  reproduction  in  any  medium,

provided the original work is properly cited.

Copyright  ©2024  Editorial  Office  of  Zoological  Research,  Kunming

Institute of Zoology, Chinese Academy of Sciences

The  mechanisms  underlying  drug  addiction  are  complex
and  involve  multiple  cell  types  within  the  brain.  Microglia,  as
essential immune cells of the central nervous system, play an
important  role  in  the  progression  of  drug  addiction.  In  this
issue,  Lin  &  Wang  (2023)  provide  valuable  insights  into  the
role  of  microglia  in  drug  addiction.  Drug  abuse  can  activate
microglia  in  the  brain,  which  subsequently  trigger  cytokine
production,  leading  to  tissue  damage  and  neuroinflammation.
The  authors  suggest
 targeting  microglia  and  their
activation  may  offer  a  potential  therapeutic  approach  to
alleviate  drug  addiction  and  related  neuroinflammatory
diseases.  They  also  summarize  specific  strategies,  including
the  inhibition  of  TLR4  signaling  associated  with  substance
abuse-induced  microglial
 activation  and  pharmacological
depletion  of  microglia.  Given  the  diverse  functional  traits  of
microglia  in  response  to  repeated  stimulation,  exploring  and
targeting  specific  microglial  subsets  provides  a  promising
novel strategy for the treatment of drug addiction.

 that

Immunotherapies such as vaccines, monoclonal antibodies,
and  catalytic  enzymes  have  gained  traction  as  potential
options  for  the  prevention  and  treatment  of  substance  use
disorders  (SUDs).  In  this  issue,  Wang  et al.  (2024)  discuss
recent advances in the development of SUD vaccines. These
vaccines  stimulate  an  immune  response  to  the  substance  of
abuse,  producing  antibodies  that  prevent  the  substance  from
crossing the blood-brain barrier, thereby blocking its rewarding
effects.  Developing  effective  vaccines  is  challenging  due  to
the need to elicit an immune response to small molecules, or
haptens,  which  are  not  typically  recognized  by  the  immune
system.  To  address  this,  haptens  can  be  conjugated  with
larger  carrier  proteins  to  form  a  complex  that  can  be
recognized by the immune system. Here, the authors propose
a  novel  biomimetic  strategy  using  polymer  carriers  instead  of
 offering  advantages  such  as
traditional
tunable  properties
 biological
contamination.  This  approach  also  incorporates  molecular
adjuvants  to  enhance  vaccine  efficacy.  The  development  of
these  next-generation  vaccines  aims  to  provide  long-term
protection  against
 doses,
although  concerns  about  potential  risks,  such  as  increased
drug  intake  to  counteract  the  vaccine’s  effects,  need  to  be
addressed.

 substance  use  with  minimal

 and  reduced  risk

 protein  carriers,

 of

General  anesthesia  is  widely  used  in  clinical  practice,  yet
the  mechanism  by  which  it  causes  loss  of  consciousness
remains  poorly  understood.  In  this  issue,  Qiu  et al.  (2023)
employ  in  vivo  fiber  photometry  and  genetically  encoded
neurotransmitter  sensors  to  investigate  the  dynamics  of  five
key  neurotransmitters  (γ-aminobutyric  acid  (GABA),  glutamic
acid,  norepinephrine,  acetylcholine,  and  dopamine)  in  the
medial  prefrontal  cortex  and  primary  visual  cortex  of  mice
under  propofol  and  sevoflurane  anesthesia.  They  reveal  a
synchronized  increase  in  GABA,  glutamate,  norepinephrine,
and  acetylcholine  concentrations  during  propofol  anesthetic-
induced  loss  of  consciousness  (aLOC),  with  dopamine  levels

 
 
increasing  only  at  surgical  doses  of  propofol.  In  contrast,  the
concentrations  of  these  neurotransmitters  show  a  general
decrease  during  sevoflurane-induced  aLOC.  These  results
imply  that  the  synchronization  of  neurotransmitter  interaction
networks may play a crucial role in the loss of consciousness
induced by anesthesia.

 research  has

 demonstrated  that

General  anesthesia  is  closely  linked  to  developmental
abnormalities  of  the  central  nervous  system.  In  this  issue,
Liang et al. (2023) investigate the neurodevelopmental effects
of sevoflurane, a commonly used anesthetic, on neonatal mice
and  assess  the  potential  therapeutic  benefits  of  davunetide.
Their  study  reveals  that  neonatal  exposure  to  sevoflurane
leads  to  long-term  social  and  cognitive  impairments  in  mice,
associated  with  decreased  expression  of  the  ADNP  protein.
Previous
 recurrent
sevoflurane  administration  in  the  early  postnatal  period  can
result  in  persistent  suppression  of  Wnt/β-catenin  signaling  in
hippocampal  neurons  and  oligodendrocytes  (Liang  et al.,
2021),  while  ADNP-derived  davunetide  can  mitigate  these
impairments  by  restoring  synaptic  function  and  up-regulating
Wnt/β-catenin  signaling.  These  findings  suggest  that  ADNP
plays  a  critical  role  in  the  neurodevelopmental  toxicity  of
anesthetics, with davunetide showing promise as a treatment
for  the  prevention  of  long-term  damage  from  anesthetic
exposure.
General

 anesthetics  can  influence  brain  function  by
interacting  with  neurons  and  impacting  glial  cells,  particularly
oligodendrocytes.  In  this  issue,  Hang  et al.  (2024)  provide  a
comprehensive  review  of  the  neurotoxic  effects  of  general
 on  oligodendrocytes  in  the
anesthetic  agents  (GAAs)
developing  brain.  Oligodendrocytes  are  crucial  for  myelin
sheath  formation,
 process  for  nerve  impulse
transmission.  The  authors  discuss  how  GAAs  can  disrupt
oligodendrocyte  proliferation,  differentiation,  and  apoptosis,
potentially  leading  to  long-term  cognitive  impairments.  Their
review  further  highlights  the  impact  of  GAAs  on  various
signaling pathways and metabolic processes, which can alter
gene  expression  and  impair  myelin  sheath  construction.  The
authors  also  emphasize  the  need  for  additional  research  to
elucidate the precise mechanisms by which anesthetics target
oligodendrocytes  and  to  develop  strategies  to  reduce  the
incidence  of
 adverse  reactions  associated  with  general
anesthetic agents.

 a  critical

 yet

 progress,

Current  research  on  pain,  drug  addiction,  and  general
anesthetics  has  made  significant
 several
limitations and challenges remain. The transition from acute to
chronic  pain  is  not  well  characterized,  and  the  underlying
mechanisms  are  still  being  explored.  Future  efforts  should
focus  on  the  development  of  personalized  pain  management
strategies  based  on  individual  genetic  and  neurobiological
characteristics.  The  neurobiological  basis  of  addiction  is
complex  and  not  fully  understood,  involving  multiple  brain
systems  and  neurotransmitters.  In  addition,  the  potential
neurotoxic effects of anesthetics on developing brains are not
fully understood. By integrating multidisciplinary research from
fields  such  as  neuroscience,  psychology,  pharmacology,  and

social science, it is anticipated that our understanding of pain,
addiction,
 leading  to  the
development of more effective treatments and interventions.

 and  anesthesia  will

 deepen,

Ji Hu1,*, Ping Zheng2,*

1 School of Life Science and Technology, ShanghaiTech
University, Shanghai 201210, China
2 State Key Laboratory of Medical Neurobiology, Institutes of Brain
Science, MOE Frontier Center for Brain Science, Department of
Neurology of Zhongshan Hospital, Fudan University, Shanghai
200032, China

*Corresponding authors, E-mail: huji@shanghaitech.edu.cn;

pzheng@shmu.edu.cn

REFERENCES 

 Chiang MC, Bowen A, Schier LA, et al. 2019. Parabrachial complex: A hub

for pain and aversion. The Journal of Neuroscience: the Official Journal of

the Society For Neuroscience, 39(42): 8225–8230.

 Hang WX, Yang YC, Hu YH, et al. 2024. General anesthetic agents induce

neurotoxicity  through  oligodendrocytes  in  the  developing  brain.  Zoological

Research, 45(3): 691–703.

 Jiang  JY,  Gao  GY,  Feng  JF,  et al.  2019.  Traumatic  brain  injury  in  China.

The Lancet Neurology, 18(3): 286–295.

 Ke  J,  Lu  WC,  Jing  HY,  et al.  2024.  Functional  dissection  of  parabrachial

substrates  in  processing  nociceptive  information.  Zoological  Research,

45(3): 633–647.

 Liang L, Zeng T, Zhao Y, et al. 2021. Melatonin pretreatment alleviates the

long-term  synaptic  toxicity  and  dysmyelination  induced  by  neonatal

sevoflurane exposure via MT1 receptor-mediated Wnt signaling modulation.

Journal of Pineal Research, 71(4): e12771.

 Liang  LR,  Liu  B,  Cao  SH,  et al.  2023.  Integrated  ribosome  and  proteome

analyses reveal insights into sevoflurane-induced long-term social behavior

and  cognitive  dysfunctions  through  ADNP  inhibition  in  neonatal  mice.

Zoological Research, 45(3): 663–678.

 Lin  C,  Wang  X.  2023.  Microglia  in  drug  addiction:  A  perspective  from

neuroimmunopharmacology. Zoological Research, 45(3): 704–706.

 Lucas  S,  Hoffman  JM,  Bell  KR,  et al.  2014.  A  prospective  study  of

prevalence and characterization of headache following mild traumatic brain

injury. Cephalalgia, 34(2): 93–102.

 Qiu  GL,  Peng  LJ,  Wang  P,  et al.  2023.  In  vivo  imaging  reveals  a

synchronized correlation among neurotransmitter dynamics during propofol

and sevoflurane anesthesia. Zoological Research, 45(3): 679–690.

 Raja  SN,  Carr  DB,  Cohen  M,  et al.  2020.  The  revised  International

Association  for  the  Study  of  Pain  definition  of  pain:  concepts,  challenges,

and compromises. Pain, 161(9): 1976–1982.

 Tosello  R,  Riera  R,  Tosello  G,  et al.  2022.  Type  of  anaesthesia  for  acute

ischaemic  stroke  endovascular  treatment.  The  Cochrane  Database  of

Systematic Reviews, 7(7): Cd013690.

 Wang K, Wang H, Wang X. 2024. Next-generation vaccines for substance

use disorders. Zoological Research, 45(3): 707–708.

 Yang  D,  Nie  BB,  He  JG,  et al.  2024.  Exploring  cerebral  structural  and

functional  abnormalities  in  a  mouse  model  of  post-traumatic  headache

induced  by  mild  traumatic  brain  injury.  Zoological  Research,  45(3):

648–662.

710      www.zoores.ac.cn
